Core Viewpoint - Ralliant Corp, a spin-off from Fortive Corp, is set to commence trading on the NYSE, allowing Fortive to focus on high-growth segments while Ralliant can allocate resources more efficiently towards its capital-intensive Precision Technologies business [2][3][4]. Company Overview - Ralliant Corp will include the Precision Technologies business, operating through two segments: Test and Measurement (56% of total sales) and Sensors and Safety Systems (44% of total sales) [10]. - Fortive (ex Ralliant) will retain its Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments, which generate nearly 50% recurring revenue [5][6]. Financial Structure - Fortive will receive a $1.15 billion dividend from Ralliant, with $700 million allocated for debt repayment and the remainder for share buybacks [4][9]. - Ralliant will issue new debt of $1.15 billion to fund the cash distribution to Fortive, resulting in a pro forma cash position of $150 million and a net debt of $1.0 billion [11]. Revenue and Growth Projections - Fortive (ex Ralliant) is projected to achieve $4 billion in revenues with 29% adjusted EBITDA margins and a revenue growth of 3.6% in FY25 [6][12]. - Ralliant Corp is expected to deliver revenue growth of 3.5% in FY25 and 4.0% in FY26, with adjusted EBITDA margins of 23.7% in FY25 [13]. Valuation - Fortive (ex Ralliant) is valued using an EV/EBITDA multiple, with a 12-month price target of $62.70 based on its higher margin profile and reducing debt [16]. - Ralliant Corp is valued at a lower multiple of 12.4x 2026E adjusted EBITDA, with a 12-month price target of $52.40, reflecting its lower growth and margin profile [17].